Primary total hip arthroplasty: health related quality of life outcomes

Bagarić, Ivan; Šarac, Helena; Borovac, Josip Anđelo; Vlak, Tonko; Bekavac, Josip; Hebrang, Andrija

doi:10.1007/s00264-013-2142-8

Cited by 17 publications

(15 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… 2012 , Bagaric et al. 2014 ). By including type of fixation in the regression model and by restricting this study to THAs excluding hip resurfacing implants some of these issues are eliminated.…”

Section: Discussionmentioning

confidence: 99%

Is gain in health-related quality of life after a total hip arthroplasty depended on the comorbidity burden?

et al. 2018

View full text Add to dashboard Cite

Background and purpose — Using patient-reported health-related quality of life (HRQoL), approximately 10% of patients report some degree of dissatisfaction after a total hip arthroplasty (THA). The preoperative comorbidity burden may play a role in predicting which patients may have limited benefit from a THA. Therefore, we examined whether gain in HRQoL measured with the EuroQol-5D (EQ-5D) at 3 and 12 months of follow-up depended on the comorbidity burden in THA patientsPatients and methods — 1,582 THA patients treated at the Regional Hospital West Jutland from 2008 to 2013 were included. The comorbidity burden was collected from an administrative database and assessed with the Charlson Comorbidity Index (CCI). The CCI was divided into 3 levels: no comorbidity burden, low, and high comorbidity burden. HRQoL was measured using the EQ-5D preoperatively and at 3 and 12 months’ follow-up. Association between low and high comorbidity burden compared with no comorbidity burden and gain in HRQoL was analyzed with multiple linear regression.Results — All patients, regardless of comorbidity burden, gained significantly in HRQoL. A positive association between comorbidity burden and gain in HRQoL was found at 3-month follow-up for THA patients with a high comorbidity burden (coeff: 0.09 (95% CI 0.02 – 0.16)) compared with patients with no comorbidity burden.Interpretation — A comorbidity burden prior to THA does not preclude a gain in HRQoL up to 1 year after THA.

show abstract

Section: Discussionmentioning

confidence: 99%

Is gain in health-related quality of life after a total hip arthroplasty depended on the comorbidity burden?

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Therefore, patient-based assessments have gained importance recently (Šantić, Legović, Šestan, Jurdana, & Marinović, 2012;Shan et al, 2014). One of the most important of these is patient-reported health-related quality of life (HRQoL), which has been reported to be used in a research and clinical practice setting (Bagarić et al, 2014). HRQoL is an indicator of general well-being and also an important parameter in health services for a patient (Lin, Chang, Lee, Yang, & Tsauo, 2015).…”

Section: Introductionmentioning

confidence: 99%

Is quality of life related to risk of falling, fear of falling, and functional status in patients with hip arthroplasty?

Büker

Eraslan

Ki̇ti̇ş

et al. 2019

Physiotherapy Res Intl

View full text Add to dashboard Cite

Objective The aim of the study was to investigate the relation between health‐related quality of life and risk of falling, fear of falling, and functional status in patients with hip arthroplasty. Methods In this cross‐sectional study, 48 hips of 45 patients who aged between 33 and 79 (53.56 ± 12.50) years and had cementless total hip arthroplasty between 2010 and 2014 were evaluated. Twenty‐seven of the patients participated in the study were female (60.0%) and 18 were male (40.0%). Health‐related quality of life with Nottingham Health Profile, function of the hip joint with Harris Hip Score, risk of falling with Performance‐Oriented Motion Assessment I, and fear of falling with Falls Efficacy Scale were assessed. In addition, chair stand test, 40‐m walk test, stair‐climb test, and single leg stance test were carried out. In analysing the relationships between these parameters, Pearson correlation analysis was employed. The level of significance was considered as p < 0.05. Results Among the cases, who were evaluated 87.10 ± 45.22 (22.43–214.71) weeks after the operation, a significant correlation was found between health‐related quality of life and risk of falling, function of hip joint, and functional tests (p < 0.05). Conclusion The evaluation of the factors related to health‐related quality of life in hip arthroplasty patients may help identify patient needs and guide the rehabilitation process.

show abstract

“…It has been proven that total hip arthroplasty (THA) improves quality of life for patients. [1][2][3] Worldwide, both cemented and uncemented femoral stems are being used in THA. Studies concerning survival of these stems have shown varying results, and so far no technique can be considered superior to the other.…”

Section: Introductionmentioning

confidence: 99%

The Accolade TMZF stem fulfils the demands of modern stem design: Minimum 5-year survival in a cohort of 937 patients

Hout

Koenraadt

Wagenmakers

et al. 2018

J Orthop Surg (Hong Kong)

View full text Add to dashboard Cite

Modern hip stem design includes a prosthesis that has a predictable outcome in all total hip arthroplasty (THA) patients, regardless of approach, surgeon or patient characteristics. Introduction without a learning curve and, in cases of problems, the possibility for a simple revision are other prerequisites. The purpose of this study is to evaluate whether the Accolade TMZF stem (Stryker Orthopedics, Mahwah, New Jersey, USA) is suitable to fulfil these demands. We report our mid-term survival of the Accolade TMZF hip stem in all patients from the first implantation at our institute. Methods: From the start of using the Accolade TMZF stem (March 2009) until February 2011, 937 THA were performed by 12 surgeons using a posterolateral or anterolateral approach. Survival of the stem was calculated using Kaplan-Meier analysis. Effect of approach, patient age and comorbidity were analysed with a Cox proportional hazards' model. The learning effect was determined by comparing the number of revisions in the surgeons' first 20 THAs with their next 30 THAs and the subsequent THAs. Results: At 5 years, cumulative stem survival was 97.9% based on revisions for all reasons and 98.8% with aseptic loosening as endpoint. We found no effect of surgical approach, patient age or comorbidity on stem survival. No learning effect was found. Conclusion: The Accolade TMZF stem fulfilled the demands of modern stem design.

show abstract

Primary total hip arthroplasty: health related quality of life outcomes

Cited by 17 publications

References 34 publications

Is gain in health-related quality of life after a total hip arthroplasty depended on the comorbidity burden?

Is gain in health-related quality of life after a total hip arthroplasty depended on the comorbidity burden?

Is quality of life related to risk of falling, fear of falling, and functional status in patients with hip arthroplasty?

The Accolade TMZF stem fulfils the demands of modern stem design: Minimum 5-year survival in a cohort of 937 patients

Contact Info

Product

Resources

About